Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


17 Items
Title  Creator  Group name  Publishing year 
RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells Palassin et al. EquipeVC 2022
RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53 Jacquier et al. EquipeLL 2022-05-03
Fabrication of 3D printed antimicrobial polycaprolactone scaffolds for tissue engineering applications Radhakrishnan et al. EquipeVC 2021-01
An R package for generic modular response analysis and its application to estrogen and retinoic acid receptor crosstalk Jimenez-Dominguez et al. EquipeJC 2021-03-31
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors Palassin et al. EquipeMY 2021
Development of new biocompatible 3D printed graphene oxide-based scaffolds Belaid et al. EquipeVC 2020-05
Cytoplasmic PPAR? is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers Shao et al. EquipeVC 2020-02-21
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor ?1 Are Inversely Associated with Survival in Primary Breast Cancer Shao et al. EquipeVC 2020-01-03
The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status Jeschke et al. EquipeVC Feb 26, 2019
Prognostic relevance of RIP140 and ER? expression in unifocal versus multifocal breast cancers: a preliminary report Müller et al. EquipeVC Jan 18, 2019
Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers Linares et al. EquipeVC 2019-07
Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival Sixou et al. EquipeVC Oct 2018
Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor Voisin et al. EquipeVC 10 31, 2017
Design of Boron Nitride/Gelatin Electrospun Nanofibers for Bone Tissue Engineering Nagarajan et al. EquipeVC Oct 04, 2017
Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors Lapierre et al. EquipeMY Apr 12, 2016
Effect of tamoxifen and fulvestrant long-term treatments on ROS production and (pro/anti)-oxidant enzymes mRNA levels in a MCF-7-derived breast cancer cell line Badia et al. EquipeVC Sep 2016
Regulation of intestinal homeostasis and tumorigenesis by the transcriptional coregulator RIP140 Cavaillès and Lapierre EquipeVC 2014 Apr-Jun
17 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés